Formula PTX Stent - Dose 1
DeviceStenting of the renal artery with a PTX-coated stent (experimental) or uncoated stent (active comparator). Groups are blinded.
NCT Number: NCT01057316
The purpose of the study is to evaluate the safety and effectiveness of the PTX-coating on the Formula PTX Balloon-Expandable Stent in treatment of renal artery stenosis.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
University Hospital Ostrava, Ostrava-Poruba, Czechia
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Stenting of the renal artery with a PTX-coated stent (experimental) or uncoated stent (active comparator). Groups are blinded.
Stenting of the renal artery with a PTX-coated stent (experimental) or uncoated stent (active comparator). Groups are blinded.
Stenting of the renal artery with a PTX-coated stent (experimental) or uncoated stent (active comparator). Groups are blinded.
Time frame: 9 months
Cook Group Incorporated
Industry
Evaluation of Safety and Effectiveness of the Formula PTX Balloon-Expandable Stent for Renal Artery Stenosis
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03382301
Arterial Occlusive Diseases, Cardiovascular Diseases
Lyon, France
View Trial DetailsNCT04423458
Arterial Occlusive Diseases, Cardiovascular Diseases
London, United Kingdom
View Trial DetailsNCT02266394
Arterial Occlusive Diseases, Cardiovascular Diseases
Birmingham, Alabama, United States
View Trial DetailsNCT01673373
Arterial Occlusive Diseases, Cardiovascular Diseases
Fremont, California, United States
View Trial Details